BIOMARIN PHARMACEUTICAL INC Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2021-07-30: Form 10-Q; Exhibit 10.1; Description First Amendment, dated May 28, 2021, to the Credit Agreement by and among BioMarin Pharmaceutical Inc., as the Borrower, Bank of America, N.A., as Administrative Agent, Swing Line Lender and a Lender, and Citibank N.A. as L/C Issuer, and the Lenders party thereto, dated as of October 19, 2018, previously filed with the SEC on February 28, 2019 as Exhibit 10.48 to the Company’s Annual Report on Form 10-K (File No. 000-26727)..
- 2021-02-26: Form 10-K; Exhibit 10.32; Description Part-Time Employment Agreement with Robert A. Baffi, Ph.D. effective January 1, 2021..
| Filed | Form | Exhibit | Description |
|---|
| 2021-07-30 | 10-Q | 10.1 | First Amendment, dated May 28, 2021, to the Credit Agreement by and among BioMarin Pharmaceutical Inc., as the Borrower, Bank of America, N.A., as Administrative Agent, Swing Line Lender and a Lender, and Citibank N.A. as L/C Issuer, and the Lenders party thereto, dated as of October 19, 2018, previously filed with the SEC on February 28, 2019 as Exhibit 10.48 to the Company’s Annual Report on Form 10-K (File No. 000-26727). |
|---|
| 2021-02-26 | 10-K | 10.32 | Part-Time Employment Agreement with Robert A. Baffi, Ph.D. effective January 1, 2021. |
|---|